BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207 AND Treatment
1738 results:

  • 1. Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation and xenograft tumor growth.
    Bi CQ; Kang T; Qian YK; Kang M; Zeng XH; Li LC
    PLoS One; 2024; 19(5):e0299522. PubMed ID: 38696452
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
    Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Baicalin induces ferroptosis in HepG2 cells by inhibiting ROS-mediated PI3K/akt/FoxO3a signaling pathway].
    Zhou JQ; Li HJ; Zeng YH; Chen HH; Liang WY; Zhang J; Ding FP
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1327-1334. PubMed ID: 38621980
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Integrated analyses for identification of a three-gene signature associated with Chaihu Shugan San formula for hepatocellular carcinoma treatment.
    Xing JH; Tan RX; Huang FE; Tian N
    J Cell Mol Med; 2024 Apr; 28(8):e18211. PubMed ID: 38613352
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic Significance of Iron Metabolism and Immune-Related Genes as Risk Markers in Hepatocellular Carcinoma.
    Tang S; Chen H
    J Environ Pathol Toxicol Oncol; 2024; 43(3):51-67. PubMed ID: 38608145
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of differentially expressed mRNA/lncRNA modules in acutely regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells.
    Baek M; Kim M; Choi HI; Binas B; Cha J; Jung KH; Choi S; Chai YG
    PLoS One; 2024; 19(4):e0301663. PubMed ID: 38603701
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma.
    Cheng K; Zhou Z; Chen Q; Chen Z; Cai Y; Cai H; Wu S; Gao P; Cai Y; Zhou J; Wang X; Wu Z; Peng B
    Sci Rep; 2024 Apr; 14(1):8389. PubMed ID: 38600093
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Extracellular Vesicles Contribute to Viral-Induced Hepatocellular Carcinoma: Understanding Their Involvement in Viral Hepatitis and Their Potential as Biomarkers for Early Hepatocellular Carcinoma Detection.
    Tahir F; Farooq M; Malik MA; Manzoor S
    Viral Immunol; 2024 Apr; 37(3):159-166. PubMed ID: 38588555
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity.
    Ge B; Yan K; Sang R; Wang W; Liu X; Yu M; Liu X; Qiu Q; Zhang X
    Ecotoxicol Environ Saf; 2024 Apr; 275():116278. PubMed ID: 38564860
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via akt/mTOR/MAPK pathways in hepatocellular carcinoma cells.
    Abusaliya A; Bhosale PB; Kim HH; Park MY; Jeong SH; Lee S; Kim GS
    Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PELI1: key players in the oncogenic characteristics of pancreatic cancer.
    Fei X; Zhu C; Liu P; Liu S; Ren L; Lu R; Hou J; Gao Y; Wang X; Pan Y
    J Exp Clin Cancer Res; 2024 Mar; 43(1):91. PubMed ID: 38528516
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Combination of ethyl acetate fraction from Calotropis gigantea stem bark and sorafenib induces apoptosis in HepG2 cells.
    Chaisupasakul P; Pekthong D; Wangteeraprasert A; Kaewkong W; Somran J; Kaewpaeng N; Parhira S; Srisawang P
    PLoS One; 2024; 19(3):e0300051. PubMed ID: 38527038
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cryptocaryone induces apoptosis in human hepatocellular carcinoma cells by inhibiting aerobic glycolysis through akt and c-Src signaling pathways.
    Yu CL; Lai YW; Chen JJ; Lee JJ; Chou TH; Huang CC; Liu SC; Chen GW; Tsai CH; Wang SW
    J Food Drug Anal; 2023 Dec; 31(4):696-710. PubMed ID: 38526828
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comparison of Glecaprevir/Pibrentasvir and Sofosbuvir/Ledipasvir in Patients with Hepatitis C Virus Genotype 1 and 2 in South Korea.
    Shin HD; Song IH; Lee SH; Kim HS; Lee TH; Eun HS; Kim SH; Lee BS; Chae HB; Kim SH; Song MJ; Ko SY; Kim SB
    Korean J Gastroenterol; 2024 Mar; 83(3):111-118. PubMed ID: 38522854
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Reduced chemokine C-C motif ligand 1 expression may negatively regulate colorectal cancer progression at liver metastatic sites.
    Iwata M; Haraguchi R; Kitazawa R; Ito C; Ogawa K; Takada Y; Kitazawa S
    J Cell Mol Med; 2024 Apr; 28(7):e18193. PubMed ID: 38506205
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tyrosine phosphatase
    Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
    Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The cell death-related genes machine learning model for precise therapy and clinical drug selection in hepatocellular carcinoma.
    Du M; Qu Y; Qin L; Zheng J; Sun W
    J Cell Mol Med; 2024 Apr; 28(7):e18168. PubMed ID: 38494848
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/akt pathway: Integrating network pharmacology, molecular docking, and experimental validation.
    Wei J; Zhao X; Long F; Tian K; Wu L
    Gene; 2024 Jun; 912():148383. PubMed ID: 38493972
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Wu TH; Lin TY; Yang PM; Li WT; Yeh CT; Pan TL
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474318
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/akt signaling pathway.
    Wang R; Li R; Yang H; Chen X; Wu L; Zheng X; Jin Y
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):117. PubMed ID: 38460052
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 87.